{"id":"https://openalex.org/W4416628722","doi":"https://doi.org/10.1158/1078-0432.30707212","title":"Supplementary Table 1 from Crizotinib Has Preclinical Efficacy in Philadelphia-Negative Myeloproliferative Neoplasms","display_name":"Supplementary Table 1 from Crizotinib Has Preclinical Efficacy in Philadelphia-Negative Myeloproliferative Neoplasms","publication_year":2025,"publication_date":"2025-11-25","ids":{"openalex":"https://openalex.org/W4416628722","doi":"https://doi.org/10.1158/1078-0432.30707212"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.30707212","doi":"https://doi.org/10.1158/1078-0432.30707212","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.30707212","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.30707212","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017395365","display_name":"Lindsay Meg Gurska","orcid":"https://orcid.org/0000-0001-7664-6105","observed_orcids":["https://orcid.org/0000-0001-7664-6105"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lindsay M. Gurska","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7664-6105","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074658394","display_name":"Rachel O. Okabe","orcid":"https://orcid.org/0000-0002-6895-5204","observed_orcids":["https://orcid.org/0000-0002-6895-5204"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rachel Okabe","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6895-5204","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082040837","display_name":"Alexandra Schurer","orcid":"https://orcid.org/0000-0001-8028-838X","observed_orcids":["https://orcid.org/0000-0001-8028-838X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alexandra Schurer","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8028-838X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103073444","display_name":"Meng Maxine Tong","orcid":"https://orcid.org/0000-0001-8244-0277","observed_orcids":["https://orcid.org/0000-0001-8244-0277"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Meng Maxine Tong","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8244-0277","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003059298","display_name":"Mark Soto","orcid":"https://orcid.org/0000-0001-9996-9003","observed_orcids":["https://orcid.org/0000-0001-9996-9003"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark Soto","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9996-9003","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065834595","display_name":"Daniel Sungchul Choi","orcid":"https://orcid.org/0000-0003-3406-9113","observed_orcids":["https://orcid.org/0000-0003-3406-9113"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel Choi","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3406-9113","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074071919","display_name":"Kristina T. Ames","orcid":"https://orcid.org/0000-0002-6845-0898","observed_orcids":["https://orcid.org/0000-0002-6845-0898"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kristina Ames","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6845-0898","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055586203","display_name":"Shira G. Glushakow-Smith","orcid":"https://orcid.org/0000-0002-6012-7236","observed_orcids":["https://orcid.org/0000-0002-6012-7236"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shira Glushakow-Smith","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6012-7236","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075425748","display_name":"Allison Montoya","orcid":"https://orcid.org/0000-0002-4543-7236","observed_orcids":["https://orcid.org/0000-0002-4543-7236"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Allison Montoya","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4543-7236","affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Ellen Tein","orcid":"https://orcid.org/0000-0002-5081-6599","observed_orcids":["https://orcid.org/0000-0002-5081-6599"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ellen Tein","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5081-6599","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029793636","display_name":"Linde A. Miles","orcid":"https://orcid.org/0000-0003-3578-2842","observed_orcids":["https://orcid.org/0000-0003-3578-2842"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Linde A. Miles","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3578-2842","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040339666","display_name":"Haiying Cheng","orcid":"https://orcid.org/0000-0002-6051-2732","observed_orcids":["https://orcid.org/0000-0002-6051-2732"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Haiying Cheng","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6051-2732","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086731270","display_name":"Pamela Hankey\u2010Giblin","orcid":"https://orcid.org/0000-0002-4290-8709","observed_orcids":["https://orcid.org/0000-0002-4290-8709"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pamela Hankey-Giblin","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4290-8709","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025660159","display_name":"Ross L. Levine","orcid":"https://orcid.org/0000-0002-7884-1905","observed_orcids":["https://orcid.org/0000-0002-7884-1905"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ross L. Levine","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7884-1905","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047223992","display_name":"Swati Goel","orcid":"https://orcid.org/0000-0001-7647-8922","observed_orcids":["https://orcid.org/0000-0001-7647-8922"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Swati Goel","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7647-8922","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081356537","display_name":"Bal\u00e1zs Halmos","orcid":"https://orcid.org/0000-0001-7548-8360","observed_orcids":["https://orcid.org/0000-0001-7548-8360"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Balazs Halmos","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7548-8360","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5058562431","display_name":"Kira Gritsman","orcid":"https://orcid.org/0000-0002-1367-1167","observed_orcids":["https://orcid.org/0000-0002-1367-1167"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kira Gritsman","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1367-1167","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":0.9448000192642212,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":0.9448000192642212,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.016899999231100082,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.008200000040233135,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/crizotinib","display_name":"crizotinib","score":1.0},{"id":"https://openalex.org/keywords/philadelphia-chromosome-negative-myeloproliferative-neoplasms","display_name":"Philadelphia-negative myeloproliferative neoplasms","score":0.9670000076293945},{"id":"https://openalex.org/keywords/alk-inhibitors","display_name":"ALK inhibitors","score":0.597000002861023},{"id":"https://openalex.org/keywords/preclinical-efficacy","display_name":"preclinical efficacy","score":0.7080000042915344},{"id":"https://openalex.org/keywords/myeloproliferative-neoplasms","display_name":"myeloproliferative neoplasms","score":0.7699999809265137}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8912000060081482},{"id":"https://openalex.org/C2779422266","wikidata":"https://www.wikidata.org/wiki/Q5186964","display_name":"Crizotinib","level":4,"score":0.8118000030517578},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6474999785423279},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6431000232696533},{"id":"https://openalex.org/C45235069","wikidata":"https://www.wikidata.org/wiki/Q278425","display_name":"Table (database)","level":2,"score":0.6101999878883362},{"id":"https://openalex.org/C2776112149","wikidata":"https://www.wikidata.org/wiki/Q7383611","display_name":"Ruxolitinib","level":4,"score":0.44929999113082886},{"id":"https://openalex.org/C2910274570","wikidata":"https://www.wikidata.org/wiki/Q1898104","display_name":"Myeloproliferative Disorders","level":2,"score":0.28220000863075256},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.26109999418258667},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.25949999690055847},{"id":"https://openalex.org/C3019096185","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Complete response","level":3,"score":0.2257000058889389}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.30707212","doi":"https://doi.org/10.1158/1078-0432.30707212","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.30707212","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/30707212","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/dataset/Supplementary_Table_1_from_Crizotinib_Has_Preclinical_Efficacy_in_Philadelphia-Negative_Myeloproliferative_Neoplasms/30707212","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Dataset"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.30707212","doi":"https://doi.org/10.1158/1078-0432.30707212","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.30707212","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2471560344","https://openalex.org/W4361815416","https://openalex.org/W2062179609","https://openalex.org/W2594429331","https://openalex.org/W2572399257","https://openalex.org/W2317988465","https://openalex.org/W2136014469","https://openalex.org/W2018823244","https://openalex.org/W4226182418","https://openalex.org/W2313967710"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2025-11-25T00:00:00"}